Delivery of interleukin-22 binding protein (IL-22BP) gene by cationic micelle for colon cancer gene therapy-Reference-Cited by-同舟云学术

Delivery of interleukin-22 binding protein (IL-22BP) gene by cationic micelle for colon cancer gene therapy

Published:2018 Issue:30 Volume:8 Page:16537-16548
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Men Ke¹²³⁴⁵^ORCID,Huang Rong¹²³⁴⁵,Zhang Xueyan¹²³⁴⁵,Zhang Rui¹²³⁴⁵,Zhang Yuanfa¹²³⁴⁵,Peng Yao¹²³⁴⁵,Tong Rongsheng⁶⁷⁸⁹⁵,Yang Li¹²³⁴⁵,Wei Yuquan¹²³⁴⁵,Duan Xingmei¹²³⁴⁵

Affiliation:

1. State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy

2. West China Hospital

3. Sichuan University

4. Chengdu 610041

5. People's Republic of China

6. Individualized Medication Key Laboratory of Sichuan Province

7. Department of Pharmacy

8. Sichuan Provincial People's Hospital

9. Chengdu

Abstract

Cationic DMP micelle delivered interleukin-22BP gene efficiently inhibits colon carcinoma growth, providing a novel strategy for cancer gene therapy.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2018/RA/C8RA02580K

Reference63 articles.

1. Cancer statistics, 2018

2. Colorectal cancer statistics, 2017

3. Gene therapy clinical trials worldwide to 2012 - an update

4. Gene therapy returns to centre stage

5. First AAV gene therapy poised for landmark approval

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced nano-based strategies for mRNA tumor vaccine;Acta Pharmaceutica Sinica B;2024-01

2. Nanoparticles as Gene Vectors in Tumor Therapy;Integration of Biomaterials for Gene Therapy;2023-10-05

3. Nanoparticles for Tumor Gene Therapy;Integration of Biomaterials for Gene Therapy;2023-10-05

4. Lipid nanoparticles-loaded with toxin mRNA represents a new strategy for the treatment of solid tumors;Theranostics;2023

5. Advances in the Relationship between Interleukin-22 and Colonic Diseases;Advances in Clinical Medicine;2023